Skip to main content

Table 3 Frequency of CSCs markers positive cases

From: Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy

  NACRT(n = 17) Non-NACRT(n = 11) P-value
EpCAM(+) 58.8% 45.5% 0.700
CD24(+) 35.3% 36.4% 1.000
CD44(+) 82.4% 18.2% 0.00148
CD133(+) 29.4% 81.8% 0.0183
CXCR4(+) 47.1% 27.2% 0.435
ALDH1(+) 64.7% 18.2% 0.0237
  1. Fisher’s exact test.
  2. The bold value indicates a statistically significant result.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us